3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Not yet recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Dermatologic
1
Conditions
Melanoma
153
Carcinoma, Non-Small-Cell Lung
34
Skin Neoplasms
30
Colorectal Neoplasms
29
Breast Neoplasms
26
Lung Neoplasms
25
Carcinoma, Renal Cell
21
Carcinoma, Basal Cell
21
Ovarian Neoplasms
20
Neoplasms
20
Squamous Cell Carcinoma of Head and Neck
19
Sarcoma
19
Carcinoma, Merkel Cell
19
Prostatic Neoplasms
17
Pancreatic Neoplasms
16
Neoplasm Metastasis
15
Head and Neck Neoplasms
15
Stomach Neoplasms
13
Thyroid Neoplasms
12
Uterine Cervical Neoplasms
11
Urinary Bladder Neoplasms
11
Carcinoma, Hepatocellular
11
Lymphoma, T-Cell, Cutaneous
10
Esophageal Neoplasms
10
Carcinoma, Transitional Cell
10
Uveal Melanoma
8
Triple Negative Breast Neoplasms
8
Mycosis Fungoides
8
Gastrointestinal Neoplasms
8
Colonic Neoplasms
8
Interventions
vedolizumab
1
Photopheresis
1
Mycophenolic Acid
1
Methoxsalen
1
Infliximab
1
Azathioprine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Hepatitis
×
Dermatologic
×
30 days
×
Clear all
NCT07619898
2026-06-02
PHOENIX-ECP
Therakos LLC
Phase 2
Not yet recruiting
112 enrolled